Non-invasive biomarkers in the diagnosis of upper urinary tract urothelial carcinoma—a systematic review

Ł Białek, K Bilski, J Dobruch, W Krajewski, T Szydełko… - Cancers, 2022 - mdpi.com
Simple Summary Laboratory and imaging tests as well as endoscopic procedures are
standard diagnostic tools for the diagnosis of upper urinary tract urothelial carcinoma. We …

Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical Practice

F Lefort, Y Rhanine, M Larroquette, C Domblides… - Cancers, 2023 - mdpi.com
Simple Summary This review examines differences and similarities between upper tract
urothelial carcinoma (UTUC) and bladder urothelial carcinoma (BUC) with respect to their …

The biological impacts of CEBPD on urothelial carcinoma development and progression

TC Chan, YL Shiue, CF Li - Frontiers in Oncology, 2023 - frontiersin.org
Urothelial carcinoma (UC), which includes urinary bladder urothelial carcinoma (UBUC) and
upper tract urothelial carcinoma (UTUC), is one of the most common malignancies …

Current knowledge on genomic profiling of upper tract urothelial carcinoma

E De Lorenzis, G Albo, F Longo, C Bebi, L Boeri… - Genes, 2021 - mdpi.com
Recent research in next-generation sequencing characterized the genomic landscape of
urothelial cancer. However, the majority of the studies focused on bladder cancer (BC) …

Urine cellular DNA point mutation and methylation for identifying upper tract urinary carcinoma

W Ouyang, L Luo, J Zhang, R Xu, Q Lu, Z Xu, J Liu, P Li… - Cancers, 2022 - mdpi.com
Simple Summary It's difficult to detect upper tract urothelial carcinoma at early stage.
Invasive testing may increase risk of cancer recurrences in the bladder after radical …

Role of ureteroscopy in treatment of upper tract urothelial carcinoma

J Ng Chieng Hin, D Hettiarachchilage… - Current Urology …, 2021 - Springer
Abstract Purpose of Review Upper tract urothelial carcinoma (UTUC) is uncommon
accounting for less than 10% of all urothelial tumours. Ureteroscopic management (URS) is …

High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma

Á Széles, PT Kovács, A Csizmarik, M Váradi, P Riesz… - Biomedicines, 2022 - mdpi.com
Simple Summary This study aimed to assess the prognostic relevance of soluble serum PD-
L1 in upper tract urothelial carcinoma (UTUC) patients who underwent surgical or systemic …

Transcriptomic insights into UTUC: role of inflammatory fibrosis and potential for personalized treatment

K Li, Z Huang, G Xie, B Huang, L Song, Y Zhang… - Journal of Translational …, 2024 - Springer
Background Upper tract urothelial carcinoma (UTUC) is a rare disease, belonging to the
same category of urothelial cancers as bladder cancer (BC). Despite sharing similar non …

[HTML][HTML] Regulatory region mutations of TERT, PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas

X Xing, X Yuan, T Liu, M Dai, Y Fan, C Liu… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background: The hotspot regulatory region mutations of the TERT, PLEKHS1 and GPR126
genes have been shown to occur frequently in urothelial bladder carcinoma (UBC) …

Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study

JH Tae, MS Ha, BH Chi, IH Chang, TH Kim, SC Myung… - BMC urology, 2022 - Springer
Purpose This study aimed to evaluate the trend of adjuvant chemotherapy (AC) and
neoadjuvant chemotherapy (NAC) in patients who underwent radical nephroureterectomy …